International Business

Q&A: Dr. Reddy’s Labs targets growth following realignment

Marc Kikuchi, CEO of North America generics at Dr. Reddy’s Labs spoke with Drug Store News to discuss the state of the industry and the company's future plans.
Q&A: Ascend invests in people, customer service to stand out

John Dillaway of Ascend Labs talks to Drug Store News about the Parsippany, N.J.-based company‘s growth and strategy to stand out among generics manufacturers.
Sandoz reportedly appoints generics unit CEO

Richard Saynor has been named the new CEO of Sandoz's generics unit, according to a report from The Pharma Letter.
Walgreens Boots Alliance makes key leadership appointments

Walgreens Boots Alliance made several leadership appointments, such as naming Gunjan Bhow chief digital officer, and Annie Murphy global chief commercial officer.
REX Awards 2019: Generics

This month, Drug Store News recognizes the cream of the crop of the generics industry with our Retail Excellence Awards.
Unilever to acquire Olly Nutrition

Olly Nutrition’s collection of vitamins, minerals and supplements will be acquired by Unilever.
Wockhardt gets FDA nod for generic Dacogen

Decitabine had an annual market value of $120 million, according to February 2019 IQVIA data.
Dr. Reddy's to acquire generic injectables portfolio

Dr. Reddy's is set to 42 products with a market value of roughly $645 million.

Edgewell Personal Care to acquire shave brand Harry’s